U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C15H22N2O.ClH
Molecular Weight 282.809
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LEVOMILNACIPRAN HYDROCHLORIDE

SMILES

Cl.CCN(CC)C(=O)[C@]1(C[C@H]1CN)C2=CC=CC=C2

InChI

InChIKey=XNCDYJFPRPDERF-NQQJLSKUSA-N
InChI=1S/C15H22N2O.ClH/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12;/h5-9,13H,3-4,10-11,16H2,1-2H3;1H/t13-,15+;/m0./s1

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
LEVOMILNACIPRAN HYDROCHLORIDE
ORANGE BOOK   USAN   WHO-DD  
USAN  
Official Name English
LEVOMILNACIPRAN HYDROCHLORIDE [ORANGE BOOK]
Common Name English
F-2695 HYDROCHLORIDE
Code English
FETZIMA
Brand Name English
MILNACIPRAN HYDROCHLORIDE, (1S,2R)-
Common Name English
(1S,2R)-MILNACIPRAN HYDROCHLORIDE
Common Name English
Levomilnacipran hydrochloride [WHO-DD]
Common Name English
F 2695 HYDROCHLORIDE
Code English
F2695 HYDROCHLORIDE
Code English
CYCLOPROPANECARBOXAMIDE, 2-(AMINOMETHYL)-N,N-DIETHYL-1-PHENYL-, HYDROCHLORIDE (1:1), (1S,2R)-
Common Name English
LEVOMILNACIPRAN HYDROCHLORIDE [USAN]
Common Name English
Code System Code Type Description
RXCUI
1433211
Created by admin on Fri Dec 15 20:11:22 UTC 2023 , Edited by admin on Fri Dec 15 20:11:22 UTC 2023
PRIMARY RxNorm
ChEMBL
CHEMBL99946
Created by admin on Fri Dec 15 20:11:22 UTC 2023 , Edited by admin on Fri Dec 15 20:11:22 UTC 2023
PRIMARY
NCI_THESAURUS
C166646
Created by admin on Fri Dec 15 20:11:22 UTC 2023 , Edited by admin on Fri Dec 15 20:11:22 UTC 2023
PRIMARY
EVMPD
SUB130559
Created by admin on Fri Dec 15 20:11:22 UTC 2023 , Edited by admin on Fri Dec 15 20:11:22 UTC 2023
PRIMARY
DRUG BANK
DBSALT000107
Created by admin on Fri Dec 15 20:11:22 UTC 2023 , Edited by admin on Fri Dec 15 20:11:22 UTC 2023
PRIMARY
DAILYMED
371U2ZK31U
Created by admin on Fri Dec 15 20:11:22 UTC 2023 , Edited by admin on Fri Dec 15 20:11:22 UTC 2023
PRIMARY
EPA CompTox
DTXSID801026201
Created by admin on Fri Dec 15 20:11:22 UTC 2023 , Edited by admin on Fri Dec 15 20:11:22 UTC 2023
PRIMARY
PUBCHEM
6917778
Created by admin on Fri Dec 15 20:11:22 UTC 2023 , Edited by admin on Fri Dec 15 20:11:22 UTC 2023
PRIMARY
SMS_ID
100000156651
Created by admin on Fri Dec 15 20:11:22 UTC 2023 , Edited by admin on Fri Dec 15 20:11:22 UTC 2023
PRIMARY
CAS
175131-60-9
Created by admin on Fri Dec 15 20:11:22 UTC 2023 , Edited by admin on Fri Dec 15 20:11:22 UTC 2023
PRIMARY
USAN
YY-41
Created by admin on Fri Dec 15 20:11:22 UTC 2023 , Edited by admin on Fri Dec 15 20:11:22 UTC 2023
PRIMARY
FDA UNII
371U2ZK31U
Created by admin on Fri Dec 15 20:11:22 UTC 2023 , Edited by admin on Fri Dec 15 20:11:22 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of LEVOMILNACIPRAN
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966